Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000249248 | SCV000307129 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000372059 | SCV000414807 | benign | Primary ciliary dyskinesia | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000366426 | SCV000483823 | likely benign | Dilated Cardiomyopathy, Recessive | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000399283 | SCV000483824 | likely benign | Familial restrictive cardiomyopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000306482 | SCV000483825 | likely benign | Familial Hypertrophic Cardiomyopathy with Wolff-Parkinson-White Syndrome | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000361081 | SCV000483826 | likely benign | Hypertrophic cardiomyopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000249248 | SCV000538794 | benign | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000607076 | SCV000744928 | benign | Primary ciliary dyskinesia 2 | 2017-06-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000372059 | SCV001722423 | benign | Primary ciliary dyskinesia | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001683014 | SCV001904194 | benign | not provided | 2018-07-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000372059 | SCV002680292 | benign | Primary ciliary dyskinesia | 2016-07-07 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV001683014 | SCV005206051 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Diagnostic Laboratory, |
RCV000607076 | SCV000733928 | benign | Primary ciliary dyskinesia 2 | no assertion criteria provided | clinical testing |